News
3 Stocks to Buy for a Better Tomorrow
Buy low, and sell high. In investing, as in life, we all hope for "a better tomorrow," and one in which the decisions we make today ultimately pay off -- figuratively, and, in the case of stocks,....
5 Dividend Aristocrats With the Fastest-Growing Dividends
Many investors like to buy stocks that are known as Dividend Aristocrats. To join this elite group, an S&P 500 company must increase its dividend for at least 25 consecutive years. But just....
VISIOMED GROUP : La complémentaire santé française KOVERS choisit l'écosystème BewellConnect(R) pour commercialiser de nouveaux services de santé connectée
Paris, le 6 novembre 2017
VISIOMED GROUP (FR0011067669 – ALVMG), société spécialisée dans l'électronique médicale nouvelle génération, annonce un partenariat commercial avec QAPE pour le....
This Growing Robotics Company Is a Hit With Surgeons (Hint: It's not Intuitive Surgical)
Mazor Robotics Ltd.'s (NASDAQ: MZOR) surgical-assist robots are revolutionizing how surgeons perform spine surgery and demand for these systems could accelerate following study results showing....
True or False: Republicans Support Legalizing Marijuana?
Chances are that you'd struggle to find an industry within the U.S. that's growing at a faster and more consistent pace than legal marijuana.Colorado, one of the eight states that's legalized....
Affordable Care Act Enrollment: 5 Money-Saving Tips for 2018
It's that time of the year again: Open enrollment for the Affordable Care Act (ACA), which you probably know better as Obamacare, is in full swing. Enrollment began on Nov. 1, as it has in recent....
3 Biotech Stocks That Soared This Week: Are They Buys?
Halloween week produced treats instead of tricks for some biotech investors. Quite a few biotech stocks rose by double-digit percentages, with three in particular soaring close to 30% and higher....
These 3 Stocks Just Raised Their Dividends
Thanksgiving came early to the stock exchange last week, with a score of companies declaring increases in their dividends. To some degree that's expected, given that we're in the swing of the fall....
Why This Marijuana Stock Imploded 42% in October
Medical marijuana upstart Insys Therapeutics (NASDAQ: INSY) had a ferociously frightening month, highlighted by the arrest of its founder, the setting aside of $150 million for lawsuits, and....
Why Celgene Crashed 30% in October -- and What Now?
Few industry watchers expected much out of GED-0301, yet its failure in a phase 3 study, plus anemic sales growth for one of its most important drugs, caused Celgene Corp. (NASDAQ: CELG) shares to....
Why Stamps.com, Pacific Biosciences of California, and Frontier Communications Slumped Today
Friday was another solid day for the stock market, and the Nasdaq Composite led most major benchmark indexes higher. Strong performance by the technology sector was a key driving force behind the....
Why Exact Sciences Shares Rallied 16.7% in October
After reporting third-quarter financial results that were better than expected, Exact Sciences (NASDAQ: EXAS) shares gained 16.7% in October, according to S&P Global Market Intelligence.Exact....
Why Investors Should Be Excited About Corcept Therapeutics Plunging as Much as 18%
Shares of Corcept Therapeutics (NASDAQ: CORT), a California-based drug developer that focuses on treating severe metabolic, oncologic, and psychiatric diseases, tumbled as much as 18% during....
Here's Why ViewRay, Inc. Is Rising Today
After the company announced that it has received orders for a pair of MRIdian Linac systems, shares of ViewRay (NASDAQ: VRAY), a small-cap company focused on radiation therapy, jumped 17% as of....
Why Emergent BioSolutions Inc. Jumped Higher Today
Emergent BioSolutions (NYSE: EBS) is up 11.4% at 1:00 p.m. EDT after announcing third-quarter earnings following the closing bell yesterday. It was a solid quarter for the biodefense specialist,....
Here's Why Cerus Corporation Rose as Much as 23.6% Today
Shares of biomedical products company Cerus Corporation (NASDAQ: CERS) jumped over 21% this morning, after the company released third-quarter 2017 financial results following market close....
Here's Why Pacific Biosciences of California Is Getting Hammered Today
Shares of DNA-sequencing pioneer Pacific Biosciences of California (NASDAQ: PACB) fell as much as 21.6% this morning after the company missed third-quarter revenue estimates by a mile. While....
Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16%....
Why This Marijuana Stock Didn't Sink Despite a Huge Earnings Miss
Wall Street analysts expected Insys Therapeutics (NASDAQ: INSY) to report dismal third-quarter results. But they didn't know just how bad those results would actually be.Insys announced its....
Why Investors Are Paying a Premium for EXACT Sciences Corporation
EXACT Sciences Corporation (NASDAQ: EXAS) operates in an industry famous for cutthroat competition that strangles profitability. In this context, the stock's 300% run-up to a nosebleed-inducing....
Pacific Biosciences of California Posts Big Third Quarter Loss
So far in 2017, Pacific Biosciences of California (NASDAQ: PACB), also known as PacBio, has yet to report impressive quarterly results. In August, the genetic-sequencing company reported big....
Insulet Posts 28% Revenue Growth and Raises 2017 Outlook on Soaring International Sales
Insulet (NASDAQ: PODD) reported solid third-quarter 2017 financial results after the market closed on Thursday. The drug delivery company, which is a leader in tubeless insulin pump technology....
3 Reasons Behind Exelixis Stock's Big Bounce
After experiencing a dismal September and sliding quite a bit over the last few weeks after a rebound, Exelixis (NASDAQ: EXEL) stock enjoyed a big bounce on Thursday. The biotech announced its....
3 Reasons It's Smart to Buy Celgene's Stock Now
Celgene Corp. (NASDAQ: CELG) shares nose-dived in October following a trial failure and third-quarter financials that failed to impress. However, there are good reasons investors ought to consider....
The Precision Medicine Stock That's Revolutionizing Cancer Treatment
Foundation Medicine's (NASDAQ: FMI) genetic screening tests are leading the way in discovering what medicines will work best in cancer patients based on their DNA. As more specialized drugs....